DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Junel (Norethindrone Acetate / Ethinyl Estradiol) - Summary

 

-- advertisement --

BOX WARNING

Cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases with age and with heavy smoking (15 or more cigarettes per day) and is quite marked in women over 35 years of age. Women who use oral contraceptives are strongly advised not to smoke.

 

JUNEL SUMMARY

Junel ™ 21 Day
(norethindrone acetate and ethinyl estradiol tablets, USP)
Junel ™ Fe28 Day
(norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets*)
*Ferrous fumarate tablets are not USP for

June l 21 and Junel ™ Fe 28 are progestogen-estrogen combinations. Junel ™ Fe 1/20 and 1.5/30: Each provides a continuous dosage regimen consisting of 21 oral contraceptive tablets and seven ferrous fumarate tablets. The ferrous fumarate tablets are present to facilitate ease of drug administration via a 28-day regimen, are non-hormonal, and do not serve any therapeutic purpose. Each light yellow tablet contains norethindrone acetate (17α-ethinyl-19-nortestosterone acetate), 1 mg; ethinyl estradiol (17α-ethinyl-1,3,5(10)-estratriene-3, 17β-diol), 20 mcg.

June l 21 and Junel ™ Fe 28 are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

JUNEL NEWS HIGHLIGHTS

Media Articles Related to Junel (Norethindrone / Estradiol)

Blogs Comment On Election-Related Reproductive Rights Issues, World Contraception Day, HHS Rule
Source: Sexual Health / STDs News From Medical News Today [2008.09.29]

'Extended Cycle' Contraception Garners More Interest
Source: MedicineNet Birth Control Specialty [2008.08.25]

Male Contraception: Progress Slow but Steady
Source: MedicineNet Vasectomy Specialty [2008.04.14]

Palin Discusses Stance On Abortion Rights, EC During Interview
Source: Abortion News From Medical News Today [2008.10.02]

more>>

Published Studies Related to Junel (Norethindrone / Estradiol)

Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. [2007.09]

Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg/ethinyl estradiol 20 micro g (Loestrin 24 Fe). [2007.01]

Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. [2006.11]

Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life. [2006.09]

Effects of low-dose norethindrone acetate plus ethinyl estradiol (0.5 mg/2.5 microg) in women with postmenopausal symptoms: updated analysis of three randomized, controlled trials. [2006.06]

more>>

Clinical Trials Related to Junel (Norethindrone / Estradiol)

Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills) [Active, not recruiting]

Treatment of Hyperandrogenism vs. Insulin Resistance in Infertile PCOS Women [Not yet recruiting]

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women [Active, not recruiting]

A Study of the Effects of GSK189075 on PK Profiles of an Oral Contraceptive Pill When Given to Healthy Female Volunteers [Active, not recruiting]

Safety of Estrogens in Lupus: Birth Control Pills [Completed]

more>>

Page last updated: 2008-10-02

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008